Cargando…
Raw and Purified Clay Minerals for Drug Delivery Applications
[Image: see text] In this study, the aim was to prepare drug-releasing clay mineral particles using raw (CaMt) and purified (PMt) montmorillonite and to compare and determine the effects of purification on the properties of montmorillonite. Montmorillonite clay minerals are used in several pharmaceu...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631760/ https://www.ncbi.nlm.nih.gov/pubmed/36340105 http://dx.doi.org/10.1021/acsomega.2c04510 |
_version_ | 1784823886693531648 |
---|---|
author | Bekaroğlu, Gökçe Maide İşçi, Sevim |
author_facet | Bekaroğlu, Gökçe Maide İşçi, Sevim |
author_sort | Bekaroğlu, Gökçe Maide |
collection | PubMed |
description | [Image: see text] In this study, the aim was to prepare drug-releasing clay mineral particles using raw (CaMt) and purified (PMt) montmorillonite and to compare and determine the effects of purification on the properties of montmorillonite. Montmorillonite clay minerals are used in several pharmaceutical and cosmetic products due to their many favorable properties, such as cation exchange capacity, adsorption capability, high specific surface area, and biocompatibility. Recently, several types of clay minerals have been widely studied for drug delivery applications due to their unique properties. The purification of montmorillonite is considered as a potentially useful step which may decrease the toxicity of impurities but which may increase the adsorption capacity of the montmorillonite. However, the effects on the toxicity and drug-release properties of purified montmorillonite have never been compared to that of raw montmorillonite. Montmorillonite was purified through decomposition of carbonates, dissolution of hydroxides, oxidation of organic materials, dialysis, and sedimentation. The raw and the purified montmorillonite were characterized using XRD, FTIR, and cation exchange capacities. Then, the cytotoxicity of raw and purified montmorillonite on normal hFOB cells was investigated to assess their biocompatibility in vitro. Finally, the efficacy of montmorillonite as a drug-delivering agent was investigated in vitro using cytotoxicity assays with the MCF7 cell line. The antitumor drug doxorubicin was loaded onto particles through electrostatic forces at 97.99% for CaMt and 96.79% for PMt. The drug-loading efficiency and release behavior of both clay minerals were determined. Results showed that both raw and purified montmorillonite did not significantly reduce the viability of normal cells at low concentrations (<500 μg/mL). At high concentrations, both raw and purified montmorillonite showed significant toxicity and the effect of impurities on toxicity were also more pronounced. Although drug loading was successful for both clay minerals there were differences in their controlled drug-release behavior. Doxorubicin-loaded raw and purified clay minerals significantly reduced MCF7 cell viability similar to pure DOX. |
format | Online Article Text |
id | pubmed-9631760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-96317602022-11-04 Raw and Purified Clay Minerals for Drug Delivery Applications Bekaroğlu, Gökçe Maide İşçi, Sevim ACS Omega [Image: see text] In this study, the aim was to prepare drug-releasing clay mineral particles using raw (CaMt) and purified (PMt) montmorillonite and to compare and determine the effects of purification on the properties of montmorillonite. Montmorillonite clay minerals are used in several pharmaceutical and cosmetic products due to their many favorable properties, such as cation exchange capacity, adsorption capability, high specific surface area, and biocompatibility. Recently, several types of clay minerals have been widely studied for drug delivery applications due to their unique properties. The purification of montmorillonite is considered as a potentially useful step which may decrease the toxicity of impurities but which may increase the adsorption capacity of the montmorillonite. However, the effects on the toxicity and drug-release properties of purified montmorillonite have never been compared to that of raw montmorillonite. Montmorillonite was purified through decomposition of carbonates, dissolution of hydroxides, oxidation of organic materials, dialysis, and sedimentation. The raw and the purified montmorillonite were characterized using XRD, FTIR, and cation exchange capacities. Then, the cytotoxicity of raw and purified montmorillonite on normal hFOB cells was investigated to assess their biocompatibility in vitro. Finally, the efficacy of montmorillonite as a drug-delivering agent was investigated in vitro using cytotoxicity assays with the MCF7 cell line. The antitumor drug doxorubicin was loaded onto particles through electrostatic forces at 97.99% for CaMt and 96.79% for PMt. The drug-loading efficiency and release behavior of both clay minerals were determined. Results showed that both raw and purified montmorillonite did not significantly reduce the viability of normal cells at low concentrations (<500 μg/mL). At high concentrations, both raw and purified montmorillonite showed significant toxicity and the effect of impurities on toxicity were also more pronounced. Although drug loading was successful for both clay minerals there were differences in their controlled drug-release behavior. Doxorubicin-loaded raw and purified clay minerals significantly reduced MCF7 cell viability similar to pure DOX. American Chemical Society 2022-10-18 /pmc/articles/PMC9631760/ /pubmed/36340105 http://dx.doi.org/10.1021/acsomega.2c04510 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Bekaroğlu, Gökçe Maide İşçi, Sevim Raw and Purified Clay Minerals for Drug Delivery Applications |
title | Raw and Purified
Clay Minerals for Drug Delivery Applications |
title_full | Raw and Purified
Clay Minerals for Drug Delivery Applications |
title_fullStr | Raw and Purified
Clay Minerals for Drug Delivery Applications |
title_full_unstemmed | Raw and Purified
Clay Minerals for Drug Delivery Applications |
title_short | Raw and Purified
Clay Minerals for Drug Delivery Applications |
title_sort | raw and purified
clay minerals for drug delivery applications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631760/ https://www.ncbi.nlm.nih.gov/pubmed/36340105 http://dx.doi.org/10.1021/acsomega.2c04510 |
work_keys_str_mv | AT bekaroglugokcemaide rawandpurifiedclaymineralsfordrugdeliveryapplications AT iscisevim rawandpurifiedclaymineralsfordrugdeliveryapplications |